Answers are grounded in this paper and cite their sources.
Randomized trial assesses mobile app impact on treatment compliance in early breast cancer, suggesting potential benefits for younger patients.
Abstract Background Multidisciplinary therapy (MDT) can improve early breast cancer outcome, while its treatment completion rate is critical. This study aimed to evaluate the association of a mobile health application (RJBC-APP) information on MDT and its treatment adherence, compared with standard clinical management. Methods The RJBC-APP study is a prospective, multicenter, randomized, phase 3 clinical trial that enrolled patients with early-stage breast cancer after MDT for adjuvant treatment. Eligible patients were randomized at a 1:1 ratio into two groups: the RJBC-APP group (the mobile-based App) and the control group. The primary endpoint was 12-month adjuvant treatment compliance rate. Secondary endpoints included treatment adherence rates at 3, 6, and 24 months. Results Between October 2023 and July 2024, a total of 508 patients were randomized, and 496 were included in the final analysis (249 [50.2%] in the RJBC-APP group and 247 [49.8%] in the control group). The 12-month treatment compliance rate was 85.5% (95% confidence interval [CI]: 81.1%–90.0%) in the RJBC-APP group and 81.4% (95% CI: 76.5%–86.3%) in the control group (P = 0.212). Exploratory subgroup analysis revealed that RJBC-APP usage was associated with a higher treatment completion rate in patients aged ≤ 50 years (85.0% vs. 78.2%), whereas no comparable effect in older patients (86.2% vs. 86.0%) (P for interaction=0.043). Additionally, the RJBC-APP improved the 3-month treatment completion rate compared with control group (93.2% vs. 87.0%, P = 0.022). Conclusions The RJBC-APP did not improve 12-month adjuvant therapy compliance rate for early-stage breast cancer patients receiving MDT. While exploratory subgroup analysis indicated a potential benefit of the RJBC-APP on compliance in younger patients or in the short-term period, these should be considered as hypothesis-generating and warrant further investigation.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: